Apta-NEW1

N/A

Report date: 2024/08/01 17:45:58
NME

Base Information

Drug NameApta-NEW1
Drug Alias NameApta-NEW1
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAptabio Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAptabio Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A